Clinical Trials
4 trialsNCT04918186 2026-05-12
IPROC
Canadian Cancer Trials Group
Phase 2 Recruiting
NCT04851119 2026-05-05
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Children's Oncology Group
Phase 1/2 Recruiting
NCT05659381 2026-04-16
HOTT
GOG Foundation
Phase 3 Recruiting
NCT01000259 2017-05-05
Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer
GOG Foundation
Recruiting